Antioxidant, anti-inflammatory, and anti-apoptotic effects of zinc supplementation in testes of rats with experimentally induced diabetes

• Published in: Applied physiology, nutrition, and metabolism Vol. 43; no. 10; p. 1010
• Main Authors: Aziz, Neven M, Kamel, Maha Y, Mohamed, Manar S, Ahmed, Sabreen M
• Format: Journal Article
• Language: English
• Published: Canada 01-10-2018
• Subjects: Animals; Apoptosis - drug effects; Blood Glucose - drug effects; Blood Glucose - metabolism; Diabetes Mellitus, Experimental - blood; Diabetes Mellitus, Experimental - drug therapy; Diabetes Mellitus, Experimental - pathology; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - pathology; Dietary Supplements; Follicle Stimulating Hormone - blood; Hypoglycemic Agents - pharmacology; Inflammation Mediators - metabolism; Insulin - blood; Male; Metformin - pharmacology; Oxidative Stress - drug effects; Proto-Oncogene Proteins c-bcl-2 - metabolism; Rats; Testis - drug effects; Testis - metabolism; Testis - pathology; Testosterone - blood; Transcription Factor RelA - metabolism; Tumor Necrosis Factor-alpha - metabolism; Zinc - pharmacology; diabète; testicules; testes; metformin; metformine; diabetes; zinc; oxidative stress; stress oxydatif
• ISSN: 1715-5320
• DOI: 10.1139/apnm-2018-0070

One of the major obstacles that males with diabetes may confront is subfertility or infertility. Thus, the present study investigated the effect of co-administration of metformin and zinc (Zn) on the testes of streptozotocin-induced diabetic rats. Male albino rats were randomly divided into 4 groups: control group; untreated diabetic group; diabetic + metformin group, in which diabetic rats were treated orally with metformin (250 mg/kg) once daily for 4 weeks; and diabetic + metformin + Zn group, in which diabetic rats were treated orally with metformin in combination with Zn (10 mg/kg) once daily for 4 weeks. Concomitant administration of metformin and Zn produced a significant decrease in serum levels of glucose and insulin and testicular levels of malondialdehyde and tumor necrosis factor α. Additionally, there was a significant increase in serum levels of Zn, testosterone, and follicle-stimulating hormone, as well as testicular total antioxidant capacity and anti-apoptotic protein Bcl-2, when compared with both the diabetic and metformin-treated diabetic groups. Moreover, co-administration of Zn and metformin significantly improved testicular histopathology, with a significant reduction in percent area of collagen fibers and nuclear factor kappa B (p65) immunoreactivity and a significant increase in seminiferous tubule diameter and connexin 43 immunoreactivity as compared with the diabetic and metformin-treated diabetic groups. In conclusion, the combination of Zn and metformin was an efficacious and safe alternative treatment, as it had superior antihyperglycemic efficacy and provided additional benefits over metformin alone in rats with type 2 diabetes.